Julia Neugebauer
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Julia Neugebauer currently works at Vivoryon Therapeutics NV, as Chief Operating Officer & Executive Director from 2025.
Dr. Neugebauer also formerly worked at MorphoSys AG, as Senior Director-Investor Relations from 2020 to 2022.
Dr. Neugebauer received her doctorate degree from Ludwig-Maximilians-Universität München.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Directeur des opérations | 01/05/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| MORPHOSYS AG | Investor Relations Contact | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national